HK1200331A1 - Improving postural stability administering droxidopa - Google Patents

Improving postural stability administering droxidopa

Info

Publication number
HK1200331A1
HK1200331A1 HK15100783.4A HK15100783A HK1200331A1 HK 1200331 A1 HK1200331 A1 HK 1200331A1 HK 15100783 A HK15100783 A HK 15100783A HK 1200331 A1 HK1200331 A1 HK 1200331A1
Authority
HK
Hong Kong
Prior art keywords
postural stability
improving postural
droxidopa
administering
administering droxidopa
Prior art date
Application number
HK15100783.4A
Other languages
English (en)
Chinese (zh)
Inventor
Arthur L Hewitt
William Schwieterman
Cameron Szakacs
Gerry Rowse
Christopher Cioffi
Michael J Roberts
Original Assignee
Lundbeck Na Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck Na Ltd filed Critical Lundbeck Na Ltd
Publication of HK1200331A1 publication Critical patent/HK1200331A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK15100783.4A 2012-01-31 2015-01-23 Improving postural stability administering droxidopa HK1200331A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261592755P 2012-01-31 2012-01-31
PCT/US2013/023828 WO2013116325A1 (fr) 2012-01-31 2013-01-30 Amélioration de la stabilité posturale par administration de droxidopa

Publications (1)

Publication Number Publication Date
HK1200331A1 true HK1200331A1 (en) 2015-08-07

Family

ID=47714573

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15100783.4A HK1200331A1 (en) 2012-01-31 2015-01-23 Improving postural stability administering droxidopa

Country Status (14)

Country Link
US (1) US20130197090A1 (fr)
EP (1) EP2809315A1 (fr)
JP (1) JP2015505563A (fr)
KR (1) KR20140131335A (fr)
CN (1) CN104220059A (fr)
AU (1) AU2013215282A1 (fr)
BR (1) BR112014018851A2 (fr)
CA (1) CA2863585A1 (fr)
CO (1) CO7141467A2 (fr)
HK (1) HK1200331A1 (fr)
IL (1) IL233855A0 (fr)
IN (1) IN2014DN07196A (fr)
SG (1) SG11201404496PA (fr)
WO (1) WO2013116325A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5880913B2 (ja) * 2011-05-17 2016-03-09 三郎 佐古田 パーキンソン病の体幹症状(姿勢反射異常)の治療剤
CN104434868A (zh) * 2013-09-18 2015-03-25 重庆圣华曦药业股份有限公司 一种稳定且利于在消化道溶出的屈昔多巴口服剂型
AU2017321016B2 (en) 2016-08-30 2020-04-23 Theravance Biopharma R&D Ip, Llc Compound for use in the treatment of neurogenic orthostatic hypotension
US10902955B1 (en) * 2020-05-01 2021-01-26 Georgetown University Detecting COVID-19 using surrogates
WO2021247963A1 (fr) * 2020-06-05 2021-12-09 Senda Biosciences, Inc. (s)-alpha-fluorométhyltyrosine en tant qu'inhibiteurs de décarboxylase pour une utilisation dans le traitement de l'hypotension

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920728A (en) 1973-08-22 1975-11-18 Hoffmann La Roche Separation and resolution of isomeric forms of 3-(3,4-dihydroxy-phenyl)-serine
JPS5629551A (en) 1979-08-20 1981-03-24 Sumitomo Chem Co Ltd Preparation of optically active threo-3- 3,4- dihydroxyphenyl serine
US4480109A (en) 1982-01-14 1984-10-30 Sumitomo Chemical Company, Limited Process for producing threo-3-(3,4-dihydroxyphenyl)serine
CA1223602A (fr) 1983-05-25 1987-06-30 Naohito Ohashi Preparation de 3-(3,4-dihydroxyphenyl)-serine
JPS6098995A (ja) 1983-11-04 1985-06-01 Microbial Chem Res Found 光学活性3−(3,4−ジヒドロキシフエニル)セリン,およびその誘導体の製造法
US5288898A (en) 1985-09-30 1994-02-22 Zaidan Hojim Biseibutsu Kagaku Kenkyu Kai N-methylphenylserine alkyl ester derivatives and uses thereof
DK175069B1 (da) 1986-03-11 2004-05-24 Hoffmann La Roche Pyrocatecholderivater
YU213587A (en) 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
DE19619510A1 (de) 1995-05-18 1996-11-21 Sumitomo Chemical Co Verfahren zur Herstellung von Threo-3-(3,4-dihydroxyphenyl)serin
GB9510481D0 (en) 1995-05-24 1995-07-19 Orion Yhtymae Oy New catechol derivatives
GB2344819A (en) 1998-12-18 2000-06-21 Portela & Ca Sa 2-Phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones
US7795307B2 (en) 2003-10-21 2010-09-14 Colucid Pharmaceuticals, Inc. Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
WO2006123678A1 (fr) * 2005-05-18 2006-11-23 Dainippon Sumitomo Pharma Co., Ltd. Comprimé stable contenant de la droxidopa
EP2363123A1 (fr) 2006-06-28 2011-09-07 Chelsea Therapeutics, Inc. Compositions pharmaceutiques comprenant du droxidopa
AU2008226541B2 (en) 2007-03-09 2013-05-09 Chelsea Therapeutics, Inc. Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia

Also Published As

Publication number Publication date
CA2863585A1 (fr) 2013-08-08
JP2015505563A (ja) 2015-02-23
BR112014018851A2 (pt) 2017-07-04
EP2809315A1 (fr) 2014-12-10
AU2013215282A1 (en) 2014-08-28
CN104220059A (zh) 2014-12-17
IL233855A0 (en) 2014-09-30
CO7141467A2 (es) 2014-12-12
KR20140131335A (ko) 2014-11-12
SG11201404496PA (en) 2014-12-30
IN2014DN07196A (fr) 2015-04-24
WO2013116325A1 (fr) 2013-08-08
US20130197090A1 (en) 2013-08-01

Similar Documents

Publication Publication Date Title
EP2910147A4 (fr) Chaise
AU345839S (en) Chair
EP2910148A4 (fr) Chaise
HK1203812A1 (en) Novel pharmaceutical formulations
HK1214242A1 (zh) 苯甲酰胺
PL2822424T3 (pl) Funkcjonalny fotel
EP2934482A4 (fr) Formulations de rétention gastrique
HK1205892A1 (en) Chair construction
HK1200331A1 (en) Improving postural stability administering droxidopa
PT2908835T (pt) Formulações estáveis
PL2734192T3 (pl) Musująca postać dawkowana
AU346460S (en) High chair
EP2864345A4 (fr) Conjugués particule-acide nucléique et utilisations thérapeutiques associées
HK1205683A1 (en) Pharmaceutical formulation having improved stability
GB201205189D0 (en) Novel medical use
EP2804853A4 (fr) Utilisations thérapeutiques
HK1209339A1 (en) Pharmaceutical formulations
GB201219818D0 (en) Chair
AU343975S (en) Chair
AU343977S (en) Chair
AU342839S (en) Chair
AU343052S (en) Chair
GB201221001D0 (en) Action chair
AU342388S (en) Foot peg 5
AU341779S (en) Foot peg 4